Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 2.252B
March 31, 2026 2.174B
December 31, 2025 2.351B
September 30, 2025 2.386B
June 30, 2025 2.188B
March 31, 2025 1.962B
December 31, 2024 2.000B
September 30, 2024 2.088B
June 30, 2024 2.051B
March 31, 2024 1.972B
December 31, 2023 2.127B
September 30, 2023 1.902B
June 30, 2023 2.197B
March 31, 2023 1.922B
December 31, 2022 1.778B
September 30, 2022 1.620B
June 30, 2022 1.691B
March 31, 2022 1.794B
December 31, 2021 1.848B
September 30, 2021 1.577B
June 30, 2021 1.596B
March 31, 2021 1.541B
December 31, 2020 1.440B
September 30, 2020 1.489B
June 30, 2020 1.393B
Date Value
March 31, 2020 1.324B
December 31, 2019 1.059B
September 30, 2019 374.27M
June 30, 2019 407.70M
March 31, 2019 415.39M
December 31, 2018 468.90M
September 30, 2018 483.36M
June 30, 2018 494.49M
March 31, 2018 499.90M
December 31, 2017 508.46M
September 30, 2017 463.28M
June 30, 2017 470.67M
March 31, 2017 414.45M
December 31, 2016 400.55M
September 30, 2016 389.82M
June 30, 2016 370.58M
March 31, 2016 284.89M
December 31, 2015 289.57M
September 30, 2015 320.07M
June 30, 2015 331.67M
March 31, 2015 354.21M
December 31, 2014 306.69M
September 30, 2014 214.47M
June 30, 2014 230.51M
March 31, 2014 245.97M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Evaxion AS 19.38M
Genmab A/S 12.51B
Ascendis Pharma A/S 2.614B
Zealand Pharma A/S 3.023B
Agenus, Inc. 172.69M

Total Assets (Quarterly) Related Metrics